These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8593018)

  • 1. Pharmacokinetics of intravenously administered isepamicin in men.
    Lin CC; Radwanski E; Korduba C; Cayen M; Affrime M
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2774-8. PubMed ID: 8593018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intramuscularly administered isepamicin in man.
    Lin CC; Radwanski E; Korduba C; Affrime M; Cayen MN
    Chemotherapy; 1997; 43(2):86-93. PubMed ID: 9084916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration.
    Lin C; Korduba C; Affrime M; Radwanski E; Nomeir A; Batra V; Cutler D; Cayen MN
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2201-3. PubMed ID: 8619567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and pharmacodynamics of isepamicin.
    Tod M; Padoin C; Petitjean O
    Clin Pharmacokinet; 2000 Mar; 38(3):205-23. PubMed ID: 10749517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of isepamicin.
    Barr WH; Colucci R; Radwanski E; Zampaglione N; Cutler D; Lin CC; Elliott M; Affrime MB
    J Chemother; 1995 Jun; 7 Suppl 2():53-61. PubMed ID: 8622111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.
    Radwanski E; Batra V; Cayen M; Korduba C; Cutler D; Affrime M; Nomeir A; Lin CC
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1794-6. PubMed ID: 9257763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers.
    Nomeir AA; Radwanski E; Cutler D; Affrime M; Christopher D; Korduba C; Batra V; Lin CC; Cayen MN
    J Clin Pharmacol; 1997 Nov; 37(11):1021-30. PubMed ID: 9505995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of isepamicin in paediatric patients.
    Scaglione F; Viganò A; Colucci R; Zampaglione N; Lin CC; Cutler D; Guerciolini R; Elliott M; Affrime M; Radwanski E
    J Chemother; 1995 Jun; 7 Suppl 2():63-9. PubMed ID: 8622112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease.
    Halstenson CE; Wong MO; Herman CS; Heim-Duthoy KL; Teal MA; Affrime MB; Kelloway JH; Keane WF; Awni WM
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1832-6. PubMed ID: 1416875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
    Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):188-201. PubMed ID: 3586328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.
    Yombi JC; Wallemacq P; Leal T; Gala JL; Vandercam B
    J Chemother; 2005 Oct; 17(5):521-6. PubMed ID: 16323441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the safety of isepamicin in adults.
    Blum D
    J Chemother; 1995 Jun; 7 Suppl 2():87-93. PubMed ID: 8622116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study.
    Tod M; Minozzi C; Beaucaire G; Ponsonnet D; Cougnard J; Petitjean O
    J Antimicrob Chemother; 1999 Jul; 44(1):99-108. PubMed ID: 10459816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion of isepamicin into cancellous and cortical bone tissue.
    Boselli E; Breilh D; Bel JC; Debon R; Saux MC; Chassard D; Allaouchiche B
    J Chemother; 2002 Aug; 14(4):361-5. PubMed ID: 12420853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic study of isepamicin with intensive care unit patients.
    Tod M; Padoin C; Minozzi C; Cougnard J; Petitjean O
    Antimicrob Agents Chemother; 1996 Apr; 40(4):983-7. PubMed ID: 8849264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.
    Breilh D; Allaouchiche B; Jaumain H; Boulétreau P; Chassard D; Malbec I; Ducint D; Saux MC
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2409-11. PubMed ID: 10508016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
    Beaucaire G
    J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.